Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Century Therapeutics | IPSC | Sep 30, 2024 | 1.71 | +6.21 |
Cepton | CPTN | Sep 30, 2024 | 3.12 | +1.30 |
Ceragon Networks | CRNT | Sep 30, 2024 | 2.74 | +0.37 |
Cerence | CRNC | Sep 30, 2024 | 3.15 | +6.78 |
CERo Therapeutics | CERO | Sep 30, 2024 | 0.09 | +1.41 |
Certara | CERT | Sep 30, 2024 | 11.71 | -0.34 |
Cerus | CERS | Sep 30, 2024 | 1.74 | -0.57 |
CervoMed | CRVO | Sep 30, 2024 | 14.60 | -3.50 |
CEVA | CEVA | Sep 30, 2024 | 24.15 | -0.82 |
CF Acquisition VII A | CFFS | Sep 30, 2024 | 11.10 | -0.27 |
CF Bankshares | CFBK | Sep 30, 2024 | 21.65 | -0.87 |
CF Industries | CF | Sep 30, 2024 | 85.80 | +0.19 |
CFSB Bancorp | CFSB | Sep 30, 2024 | 6.90 | +2.45 |
CG Oncology | CGON | Sep 30, 2024 | 37.73 | -0.37 |
CGI | GIB | Sep 30, 2024 | 114.96 | +0.65 |
Chain Bridge I SPAC A | CBRG | Sep 30, 2024 | 11.29 | +0.18 |
Chain Bridge I Units | CBRGU | Sep 30, 2024 | 11.11 | 0.00 |
Champion Homes | SKY | Sep 30, 2024 | 94.85 | +0.58 |
Champions Oncology | CSBR | Sep 30, 2024 | 4.87 | +3.18 |
ChampionX | CHX | Sep 30, 2024 | 30.15 | -0.50 |
Chanson International | CHSN | Sep 30, 2024 | 2.77 | -2.81 |
ChargePoint | CHPT | Sep 30, 2024 | 1.37 | 0.00 |
Charles & Colvard | CTHR | Sep 30, 2024 | 1.73 | +6.13 |
Charles River Laboratories International | CRL | Sep 30, 2024 | 196.97 | -0.68 |
Charles Schwab | SCHW | Sep 30, 2024 | 64.81 | +0.61 |
Chart Industries | GTLS | Sep 30, 2024 | 124.14 | -1.24 |
Chart Industries | GTLS-B | Sep 30, 2024 | 50.25 | -2.12 |
Charter Communications A | CHTR | Sep 30, 2024 | 324.08 | -0.66 |
Chatham Lodging Trust (REIT) A Pref | CLDT-A | Sep 30, 2024 | 23.15 | -1.53 |
Chatham Lodging Trust REIT | CLDT | Sep 30, 2024 | 8.52 | -1.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.